Sabra Healthcare REITSBRA
SBRA
0
Funds holding %
of 7,425 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
174% more call options, than puts
Call options by funds: $4.27M | Put options by funds: $1.56M
56% more repeat investments, than reductions
Existing positions increased: 154 | Existing positions reduced: 99
38% more first-time investments, than exits
New positions opened: 54 | Existing positions closed: 39
2.52% more ownership
Funds ownership: 95.05% [Q3] → 97.57% (+2.52%) [Q4]
2% more funds holding
Funds holding: 373 [Q3] → 379 (+6) [Q4]
4% less capital invested
Capital invested by funds: $4.14B [Q3] → $3.96B (-$185M) [Q4]
25% less funds holding in top 10
Funds holding in top 10: 4 [Q3] → 3 (-1) [Q4]
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$18
1%
upside
Avg. target
$19
6%
upside
High target
$20
12%
upside
2 analyst ratings
1 positive
50%
1 neutral
50%
0 negative
0%
Truist Securities Michael Lewis 43% 1-year accuracy 13 / 30 met price target | 1%upside $18 | Hold Maintained | 18 Mar 2025 |
Citizens Capital Markets Matthew Carletti 64% 1-year accuracy 38 / 59 met price target | 12%upside $20 | Market Outperform Reiterated | 21 Feb 2025 |
Financial journalist opinion
Based on 3 articles about SBRA published over the past 30 days
Positive
Seeking Alpha
2 days ago
Sabra Health Care REIT: 7% Yield And Aging Population Make It A Downturn-Ready Pick
Sabra Health Care REIT's strong fundamentals, 6.62% dividend yield, and low forward multiple make it an attractive investment amid tariff uncertainties and potential recession. The REIT's solid growth in FFO, AFFO, and revenue, driven by increased occupancy rates and NOI growth, highlights its resilience in a challenging economic environment. Sabra's well-positioned balance sheet, with robust liquidity and deleveraging efforts, ensures stability and growth potential, even during economic downturns.
Neutral
Business Wire
1 week ago
Sabra Health Care REIT, Inc. Announces First Quarter 2025 Earnings Release Date and Conference Call
TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #1Q25--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2025 first quarter earnings release on May 5, 2025, after the close of trading. A conference call with a simultaneous webcast to discuss the 2025 first quarter results will be held on Tuesday, May 6th at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number.
Neutral
CNBC Television
3 weeks ago
Final Trades: Amgen, Sabra Health Care and Kinsale Capital Group
Final Trades: Amgen, Sabra Health Care and Kinsale Capital Group.
Neutral
Business Wire
1 month ago
Sabra Health Care REIT, Inc. to Attend Deutsche Bank's 2025 Healthcare REIT Summit
TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #DBHealthcareREITSummit--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Michael Costa, the company's Chief Financial Officer, Talya Nevo-Hacohen, the company's Chief Investment Officer, Jessica Flores, the company's Chief Accounting Officer, Darrin Smith, the company's Executive Vice President of Investments, and Lukas Hartwich, the company's Executive Vice President of Finance, will attend Deutsche Bank's 2.
Neutral
Business Wire
1 month ago
Sabra Health Care REIT, Inc. Announces Chief Investment Officer Transition
TUSTIN, Calif.--(BUSINESS WIRE)---- $CIO #CIO--Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) today announced that Talya Nevo-Hacohen, Sabra's Chief Investment Officer, Treasurer and Executive Vice President, has decided to retire effective December 31, 2025 and Darrin Smith, Sabra's Executive Vice President, Investments, is expected to be elevated to the role of Sabra's Chief Investment Officer effective January 1, 2026. Ms. Nevo-Hacohen is expected to remain in a consulting role with Sabra pursuant.
Positive
Seeking Alpha
1 month ago
Sabra Health Care REIT: Come For Income, Stay For Growth
Sabra Health Care REIT, Inc. offers a 6.7% dividend yield, benefiting from strong fundamentals, favorable demographics, and a well-managed balance sheet. Management is guiding for AFFO growth, supported by rising occupancy, stable reimbursement rates, and a robust acquisition pipeline in skilled nursing. SBRA stock trades at a reasonable valuation with a forward P/FFO of 12.2, positioning it for potential market-beating total returns.
Positive
Seeking Alpha
1 month ago
7 Stocks I'm Buying As The U.S. Economy Starts To Crack
I emphasize the importance of nonpartisan economic and investment analysis, highlighting how political biases can distort market expectations and investment decisions. Medicaid cuts would likely have little impact on skilled nursing facility REITs, and the current selloff presents a buying opportunity for CareTrust REIT. Single-family rental REITs face challenges from high home prices and mortgage rates, but offer quality rental homes and professional management.
Neutral
Seeking Alpha
2 months ago
Sabra Health Care REIT, Inc. (SBRA) Q4 2024 Earnings Call Transcript
Sabra Health Care REIT, Inc. (NASDAQ:SBRA ) Q4 2024 Earnings Conference Call February 20, 2025 1:00 PM ET Company Participants Lukas Hartwich - EVP, Finance Rick Matros - CEO, President & Chair Talya Nevo-Hacohen - CIO, Treasurer & EVP Mike Costa - CFO Conference Call Participants Farrell Granath - Bank of America John Kilichowski - Wells Fargo Michael Griffin - Citi Research Austin Wurschmidt - KeyBanc Capital Markets Georgi Dinkov - Mizuho Juan Sanabria - BMO Capital Markets Richard Anderson - Wedbush Alec Feygin - Baird Equity Research Michael Stroyeck - Green Street Aaron Hecht - JMP Securities Omotayo Okusanya - Deutsche Bank Operator Good day. My name is Aaron, and I will be your conference operator for today.
Positive
Zacks Investment Research
2 months ago
Sabra (SBRA) Reports Q4 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Sabra (SBRA) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Positive
Zacks Investment Research
2 months ago
Sabra Healthcare (SBRA) Q4 FFO Match Estimates
Sabra Healthcare (SBRA) came out with quarterly funds from operations (FFO) of $0.36 per share, in line with the Zacks Consensus Estimate. This compares to FFO of $0.33 per share a year ago.
Charts implemented using Lightweight Charts™